MedPath

PF-06818883

Generic Name
PF-06818883

Safety and Tolerability of PF-06818883 in Healthy Subjects

Phase 1
Terminated
Conditions
Healthy
Interventions
Drug: Placebo
First Posted Date
2017-01-13
Last Posted Date
2017-12-11
Lead Sponsor
Pfizer
Target Recruit Count
30
Registration Number
NCT03020784
Locations
🇺🇸

Pfizer New Haven Clinical Research Unit, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath